|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 14.30 USD | -0.69% |
|
-6.54% | -37.83% |
| 09-04 | Ionis Pharma prices first FDA-approved treatment for Alexander disease at $285,000 per dose | RE |
| 09-03 | Top Midday Decliners | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RARE | Delayed | |
CBOE
| RARE | Real-time | |
|
Börse Stuttgart
| UP0 | Delayed | |
|
Tradegate
| UP0 | Real-time | |
|
Mexican S.E.
| RARE * | End-of-day quote | |
|
Berne S.E.
| UP0 | End-of-day quote | |
|
London S.E.
| 0LIF | Delayed | |
|
Deutsche Boerse AG
| UP0 | Delayed | |
|
Boerse Muenchen
| UP0 | Real-time | |
Sao Paulo
| R2AR34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 19.3 | 21.59 | 24.91 |
| Spread/Res. | -25.91% | -33.77% | -42.59% |
| Spread/Supp. | +44.33% | +44.33% | +14.67% |
| Support | 9.908 | 9.908 | 12.47 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RARE Stock
- Charts Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
